Clinical use of inhaled corticosteroids in asthma

Journal of Allergy and Clinical Immunology

Volumn 97, Issue 1 II, 1996, Pages 177-182

  Wasserfallen, J B ^a   Baraniuk, J N ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; ESTROGEN; FLUNISOLIDE; FLUTICASONE PROPIONATE; IPRATROPIUM BROMIDE; LODOXAMIDE; NEDOCROMIL SODIUM; PREDNISONE; THEOPHYLLINE; TIXOCORTOL PIVALATE; TRIAMCINOLONE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHITIS; BRONCHUS BIOPSY; CATARACT; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG COST; DRUG EFFICACY; DYSPHONIA; HUMAN; INHALATIONAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL;

EID: 0030064151     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)80218-1     Document Type: Article

References (41)

1. International Consensus Report on Diagnosis and Treatment of Asthma 1992 National Heart, Lung, and Blood Institute, National Institutes of Health Bethesda, Md.
2. Barnes P.J. Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma Am Rev Respir Dis 148 1993 S1 S26
3. Schleimer R.P. Effects of glucocorticoids on inflammatory cells relevant to their therapeutic application in asthma Am Rev Respir Dis 141 1990 S59 S69
4. Laitinen L.A. Laitinen A. Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and of a β2 agonist, terbutaline, on airway inflammation in newly diagnosed asthma J Allergy Clin Immunol 90 1992 32 42
5. Beasley R. Roche W.R. Roberts J.A. Holgate S.T. Cellular events in the bronchi in mild asthma and after bronchial provocation Am Rev Respir Dis 139 1989 806 817
6. Laitinen L.A. Laitinen A. Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma Am Rev Respir Dis 147 1993 697 704
7. Dukes M.N.G. Holgate S.T. Pauwels R.A. Report of an international workshop on risk and safety of asthma therapy Clin Exp Allergy 24 1994 160 165
8. Barnes P.J. Inflammatory mechanism and nocturnal asthma Am J Med 85 suppl 1B 1988 64 70
9. (suppl) Barnes P.J. Effect of corticosteroids on airway hyperresponsiveness Am Rev Respir Dis 141 1990 S70 S76
10. Cockroft D.W. Murdoch K.Y. Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine J Allergy Clin Immunol 79 1987 734 740
11. Dahl R. Johansson S.-A. Importance of duration of treatment with inhaled budesonide on the immediate and late bronchial reaction Eur J Respir Dis 62 suppl 122 1982 S167 S175
12. Juniper E.F. Kline P.A. Vanzieleghem M.A. Ramsdale E.H. O'Byrne P.M. Hargreave F.E. Long term effect of budesonide on airway responsiveness and clinical asthma severity in inhaled steroid-dependent asthmatics Eur Respir J 3 1990 1122 1127
13. Malo J.L. Cartier A. Merland N. Four-times-a-day dosing frequency is better than twice-a-day regimen in subjects requiring a high-dose inhaled steroid, budesonide, to control moderate to severe asthma Am Rev Respir Dis 140 1989 624 628
14. Vathenen A.S. Knox A.J. Wisniewski A. Tattersfield A.E. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma Am Rev Respir Dis 143 1991 1317 1321
15. Haahtela T. Järvinen M. Kava T Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma N Engl J Med 331 1994 700 705
16. Juniper E.F. Kline P.A. Vanzieleghem M.A. Hargreave F.E. Reduction of budesonide after a year of increased use: a randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained J Allergy Clin Immunol 87 1991 483 489
17. Lundgren R. Söderberg M. Hörstedt P. Stenling R. Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids Eur Respir J 1 1988 883 889
18. Mawhinney H. Spector S.L. Kinsman R.A. Compliance in clinical trials of nonbronchodilator, anti-asthma medications Ann Allergy 66 1991 294 299
19. Mann M. Eliasson O. Patel K. ZuWallack R.L. A comparison of the effects of bid and qid dosing in compliance with inhaled flunisolide Chest 101 1992 496 499
20. Boe J. Rosenhall L. Alton M. Comparison of doseresponse effects of inhaled beclomethasone dipropionate and budesonide in the management of asthma Allergy 44 1989 349 355
21. Ebden P. Jenkins A. Houston G. Davies B.H. Comparison of two high-dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 μg/day) and budesonide (1600 μg/day) for chronic asthma Thorax 41 1986 869 874
22. Leblanc P. Mink S. Keistinen T. Saarelainen P.A. Ringdal N. Payne S.L. A comparison of fluticasone propionate 200 μg/day with beclomethasone dipropionate 400 μg/day in adult asthma Allergy 49 1994 380 385
23. Fabbri L. Burge P.S. Croonenborgh L. A comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year Thorax 48 1993 817 823
24. Toogood J.H. Baskerville J.C. Markov A.E. Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma J Allergy Clin Immunol 96 1995 157 166
25. Padfield P.L. Teelucksingh S. Inhaled corticosteroids-the endocrinologists' view Eur Respir Rev 3 1993 494 500
26. Kruszynska Y.T. Greenstone M. Home P.D. Cooke N.J. Effect of high dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects Thorax 42 1987 881 884
27. Doull I.J. Freezer N.J. Holgate S.T. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate Am J Respir Crit Care Med 151 1995 1715 1719
28. (Abstract) Pedersen S. Agertoft L. Effect of long term budesonide treatment on growth, weight, and lung function in children with asthma Am Rev Respir Dis 147 1993 A265
29. Toogood J.F. Markov A.E. Baskerville J. Dyson C. Association of ocular cataracts with inhaled and oral steroid therapy during long-term treatment of asthma J Allergy Clin Immunol 91 1993 571 579
30. Capewell S. Reynolds S. Shuttleworth D. Edwards C. Finlay A.Y. Purpura and dermal thinning associated with high dose inhaled corticosteroids BMJ 300 1990 1548 1551
31. Mak V.H.F. Melchor S. Spiro S.G. Easy bruising as a side-effect of inhaled corticosteroids Eur Respir J 5 1992 1068 1074
32. Toogood J.H. Jennings B. Baskerville J. Anderson J. Johannsen S.A. Dosing regimen of budesonide and occurrence of oropharyngeal complications Eur J Respir Dis 65 1984 35 44
33. Weiss K.B. Gergen P.J. Hodgson T.A. An economic evaluation of asthma in the United States N Engl J Med 326 1992 862 866
34. Bregenzer T. Mossinger C. Medici T.C. Therapiewandel and Kostenentwicklung des Asthma bronchiale: Fine retrospektive Studie fiber die letzten 10 Jahre an der Medizinischen Poliklinik des Universitätspitals Zurich Pneumologie 44 1990 960 966
35. Eisenberg J.M. Clinical economics: a guide to the economic analysis of clinical practices JAMA 262 1989 2879 2886
36. Adelroth E. Thompson S. Advantages of high-dose inhaled budesonide Lancet 1 8583 1988 476
37. Gerdtham U.G. Hertzman P. Boman G. Impact of inhaled corticosteroids on asthma hospitalization in Sweden: a pooled regression analysis Research Report of the Ekonomiska Forskningsinstitutet 1993 Center for Health Economics, Stockholm School of Economics
38. Campbell L.M. Simpson R.J. Turbitt M.L. A comparison of the cost-effectiveness of budesonide 400 μg/day and 800 μg/day in the management of mild to moderate asthma in general practice Br J Med Econ 6 1993 67 74
39. Connett G.J. Lenney W. McConchie S.M. The cost-effectiveness of budesonide in severe asthmatics aged one to three years Br J Med Econ 6 1993 127 134
40. Rutten-van Mölken M.P.M.H. Van Doorslaer E.K.A. Jansen M.C.C. Cost-effectiveness of inhaled corticosteroid plus bronchodilator therapy versus bronchodilator monotherapy in children with asthma Pharmacoeconomics 4 1993 257 270
41. Rutten-van Mölken M.P.M.H. Van Doorslaer E.K.A. Jansen M.C.C. Kerstjens H.A.M. Rutten F.F.H. Costs and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease Am J Respir Crit Care Med 151 1995 975 982